Cyclodextrins in drug delivery: An updated review

被引:942
作者
Challa, R [1 ]
Ahuja, A [1 ]
Ali, J [1 ]
Khar, RK [1 ]
机构
[1] Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India
关键词
cyclodextrins; drug formulation; drug delivery; novel delivery systems; excipients;
D O I
10.1208/pt060243
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this review is to discuss and summarize some of the interesting findings and applications of cyclodextrins (CDs) and their derivatives in different areas of drug delivery, particularly in protein and peptide drug delivery and gene delivery. The article highlights important CD applications in the design of various novel delivery systems like liposomes, microspheres, microcapsules, and nanoparticles. In addition to their well-known effects on drug solubility and dissolution, bioavailability, safety, and stability, their use as excipients in drug formulation are also discussed in this article. The article also focuses on various factors influencing inclusion complex formation because an understanding of the same is necessary for proper handling of these versatile materials. Some important considerations in selecting CDs in drug formulation such as their commercial availability, regulatory status, and patent status are also summarized. CDs, because of their continuing ability to find several novel applications in drug delivery, are expected to solve many problems associated with the delivery of different novel drugs through different delivery routes.
引用
收藏
页数:29
相关论文
共 243 条
[81]   SLOW-RELEASE CHARACTERISTICS OF DILTIAZEM FROM ETHYLATED BETA-CYCLODEXTRIN COMPLEXES [J].
HORIUCHI, Y ;
HIRAYAMA, F ;
UEKAMA, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (02) :128-132
[82]   Effects of structure of β-cyclodextrin-containing polymers on gene delivery [J].
Hwang, SJ ;
Bellocq, NC ;
Davis, ME .
BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :280-290
[83]  
*INT SPEC PROD, 2000, CYCL PHARM APPL TECH
[84]   Cyclodextrins in peptide and protein delivery [J].
Irie, T ;
Uekama, K .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :101-123
[85]   Pharmaceutical applications of cyclodextrins .3. Toxicological issues and safety evaluation [J].
Irie, T ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (02) :147-162
[86]   Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity - drug supersaturation, toxicity on TR146 cells and release from a delivery system [J].
Jacobsen, J ;
Bjerregaard, S ;
Pedersen, M .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 48 (03) :217-224
[87]   Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 β-cyclodextrin (SBE 7) complexes [J].
Jain, AC ;
Aungst, BJ ;
Adeyeye, MC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (07) :1659-1668
[88]   Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether β-cyclodextrins (SBE) and danazol-SBE inclusion complexes [J].
Jain, AC ;
Adeyeye, MC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) :177-186
[89]  
Jarho P, 2000, J PHARM SCI, V89, P241, DOI 10.1002/(SICI)1520-6017(200002)89:2<241::AID-JPS11>3.0.CO
[90]  
2-0